GT Biopharma Inc (GTBP)

[simon wagstaff]

Oh so many more facts than that.

But I have posted them so no need to repeat.

I will point out that a phase III trial is likely several years away.

One of the problems with cancer trials is that if you want to have a 5 year remission rate, you have to wait 5 years to get the data.

You will need 100's of patients at multiple centers.

One complete remission out of 32 is not even close to cutting it.

And I think it's just going to be way too expensive to manufacture. 6 grams is A LOT of protein to manufacture. They need to go back to the drawing board and increase the specific activity by a factor of 10 at least.

But, as you can see, there is always somebody that stumbles into these things and think it looks like a good idea.